BIOVIE INC.
Financial highlights
| Metric | FY June 30, 2025 | FY June 30, 2024 | FY June 30, 2023 | FY June 30, 2022 | FY June 30, 2021 |
|---|---|---|---|---|---|
| Operating income | -$18.1M | -$32.2M | -$45.1M | -$27.3M | -$138.1M |
| Operating expenses | $18.1M | $32.2M | $45.1M | $27.3M | $138.1M |
| Cash from operations | -$19.0M | -$27.9M | -$40.3M | -$19.0M | -$10.5M |
| Total assets | $21.6M | $25.2M | $35.1M | $20.1M | $6.0M |
| Total liabilities | $2.6M | $9.7M | $19.8M | $16.4M | $996,374 |
Shares outstanding 7.5M · Free float 99.1%
Annual filing data through FY ended June 30, 2025; float as of June 27, 2026.